- Calmer Co has recently seen its Fiji Kava health products hit the shelves at Coles
- Products have also landed on the Walmart e-commerce platform
- Shares last at 0.6cps
Calmer Co’s (ASX:CCO) half year report has revealed company revenues are up 91% vs pcp to $1.423M with losses from activities shedded -31% v pcp.
Losses in the period were $1.68M in the latest half vs $2.68M pcp.
The data ultimately shows Calmer Co heading towards profitability, all cards in order – tantalising news for a company reporting a gross margin of 56%.
The momentum behind this feat will only be enhanced by the fact the company’s Fiji-sourced and Kava-based health and wellness drink products have recently hit the shelves at Coles, part of Australia’s supermarket duopoly.
The company saw e-sales surge 83% in the December quarter and CCO recently locked in $1M to progress 2024 activities.
But perhaps of most interest to the company is how listing its products on an e-commerce platform in the USA will see the company perform – none other than Walmart.
The Calmer Co is already on Amazon, too, where it says it’s the number 1 instant kava brand.
Sales of its 50g pouches of powdered drinking kava peaked in September last year, the company says, and its products have also now entered resorts and hotels around Fiji.
During the first half of FY24, CCO said it has modernised its supply chain by introducing digitisation aspects. Factory upgrades are also underway.
Further, the company relocated into a 40Ksq.ft. processing centre on Fiji’s main island of Navua co-located with a Kava processing company.
Shares last traded at 0.6c.
